| HOME >> BIOLOGY >> TECHNOLOGY |
Sigma-Aldrich continues to make the Acta more useful and accessible to
scientists around the world
ST. LOUIS, July 15 /PRNewswire-FirstCall/ -- Sigma-Aldrich (Nasdaq: SIAL) is proud to announce that its highly acclaimed chemistry review journal, Aldrichimica Acta, has again been ranked #1 by Impact Factor, out of 56 similar journals in the field of Organic Chemistry. In 2007, the latest year for which such rankings are available, the Acta achieved an Impact Factor of 11.929. The Acta was also ranked #1 in 2006 and 2005. These rankings appear annually in the Science Edition of Journal Citation Reports(R) (JCR), which is published by Thomson ISI(R). JCR, Science Edition, tracks close to 5,900 international science journals annually and offers quantifiable statistical data, which allows the systematic and objective ranking of journals by relative importance within their subject categories.
The Aldrichimica Acta publishes in-depth reviews on topics of current interest to chemists. It is published four times a year and distributed at no charge to about 130,000 subscribers worldwide who are members of the scientific community.
"We are extremely proud of this latest ranking of the Acta by ISI(R)," said Dr. Sharbil Firsan, Aldrichimica Acta Editor. "In particular, we are very pleased with the significant increase in Impact Factor reported. Both are a clear indication of the high regard in which our fellow chemists hold the Acta, and of its continued value to them. We continually strive to make the Acta even more useful and accessible to scientists and technologists around the world. As an example of that, all issues of the Acta that have ever been published, together with a useful index of reviews and authors, are available on our website free of charge, and will soon be available, also free of charge, on an interactive CD-ROM."
Subscription information and all issues dating back to 1968 are available online at http://www.sigma-aldrich.com/acta and will soon be available on CD.
*ISI and Journal Citation Reports are registered trademarks of The Thomson Corporation.
About Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and High Technology company. Its biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high technology manufacturing. The Company has customers in life science companies, university and government institutions, hospitals, and in industry. Over one million scientists and technologists use its products. Sigma-Aldrich operates in 36 countries and has 7,900 employees providing excellent service worldwide. Sigma-Aldrich is committed to Accelerating Customer Success through Leadership in Life Science, High Technology and Service. For more information about Sigma-Aldrich, please visit its award-winning Web site at http://www.sigma-aldrich.com.
'/>"/>
| SOURCE Sigma-Aldrich Copyright©2008 PR Newswire. All rights reserved |
Related biology technology :
1. Alma Lasers Ranked 9th in Deloitte Technology Fast 50 Award
2. Align Technology, Inc. Ranked 23rd in Deloittes Technology Fast 50 Program for Silicon Valley Scientific & Medical Equipment, and Bio-Technology Companies
3. WuXi PharmaTech (NYSE: WX) Ranked the 28th of Deloitte Technology Fast 50 China
4. CardioDynamics Ranked in Deloittes Technology Fast 50 Program for San Diego
5. ORIMtec Releases Industry's First Intraoperative Monitoring Reference Guide for Neurotechnologists
6. Controlling the size of nanoclusters: First step in making new catalysts
7. Presentation of North Americas First Certificate for BS 25999, the New Standard for Business Continuity
8. Delaware Valley Innovation Network Awards First Innovation Investment Grant to the Wistar Institute
9. Forest Laboratories, Inc. Sets Date and Conference Call for Fiscal 2009 First Quarter Earnings
10. Edmonton to be site of worlds first industrial scale municipal waste-to-ethanol facility
11. ActivBiotics Assignee Issues First Distribution of Cash to Creditors
| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |